Western Blot analysis showed that the levels of apoptotic proteins BAX and BCL2, as well as necroptotic markers RIPK1 and phosphorylated MLKL (p-MLKL), remained unchanged following Lenvatinib treatment in HCC cells (Figure 2g-j). This evidence concerns the gene MLKL and hepatocellular carcinoma.